These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1276 related articles for article (PubMed ID: 28231720)

  • 41. Tumor-associated macrophages: A promising target for a cancer immunotherapeutic strategy.
    Zhang SY; Song XY; Li Y; Ye LL; Zhou Q; Yang WB
    Pharmacol Res; 2020 Nov; 161():105111. PubMed ID: 33065284
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Macrophage-based cancer immunotherapy: Challenges and opportunities.
    Bai H; Feng L; Schmid F
    Exp Cell Res; 2024 Sep; 442(1):114198. PubMed ID: 39103071
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The interaction of anticancer therapies with tumor-associated macrophages.
    Mantovani A; Allavena P
    J Exp Med; 2015 Apr; 212(4):435-45. PubMed ID: 25753580
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Role of Antigen Presentation in Tumor-Associated Macrophages.
    Stopforth RJ; Ward ES
    Crit Rev Immunol; 2020; 40(3):205-224. PubMed ID: 33389885
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Targeting tumor-associated macrophages for cancer immunotherapy.
    Cao X; Lai SWT; Chen S; Wang S; Feng M
    Int Rev Cell Mol Biol; 2022; 368():61-108. PubMed ID: 35636930
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Macrophages and NF-κB in cancer.
    Lawrence T
    Curr Top Microbiol Immunol; 2011; 349():171-84. PubMed ID: 21080151
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activation of phagocytosis by immune checkpoint blockade.
    Li CW; Lai YJ; Hsu JL; Hung MC
    Front Med; 2018 Aug; 12(4):473-480. PubMed ID: 30062558
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Macrophage Biology and Mechanisms of Immune Suppression in Breast Cancer.
    Mehta AK; Kadel S; Townsend MG; Oliwa M; Guerriero JL
    Front Immunol; 2021; 12():643771. PubMed ID: 33968034
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Research trends in pharmacological modulation of tumor-associated macrophages.
    Wang N; Wang S; Wang X; Zheng Y; Yang B; Zhang J; Pan B; Gao J; Wang Z
    Clin Transl Med; 2021 Jan; 11(1):e288. PubMed ID: 33463063
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recent Advances in Nanoimmunotherapy by Modulating Tumor-Associated Macrophages for Cancer Therapy.
    Hao J; Zhao X; Wang C; Cao X; Liu Y
    Bioconjug Chem; 2024 Jul; 35(7):867-882. PubMed ID: 38919067
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting tumor‑associated macrophages: Critical players in tumor progression and therapeutic strategies (Review).
    Su P; Li O; Ke K; Jiang Z; Wu J; Wang Y; Mou Y; Jin W
    Int J Oncol; 2024 Jun; 64(6):. PubMed ID: 38695252
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tumor-associated macrophages: from basic research to clinical application.
    Yang L; Zhang Y
    J Hematol Oncol; 2017 Feb; 10(1):58. PubMed ID: 28241846
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Emerging Nanoparticle Strategies for Modulating Tumor-Associated Macrophage Polarization.
    Shi L; Gu H
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944555
    [TBL] [Abstract][Full Text] [Related]  

  • 54. M1-like macrophages change tumor blood vessels and microenvironment in murine melanoma.
    Jarosz-Biej M; Kamińska N; Matuszczak S; Cichoń T; Pamuła-Piłat J; Czapla J; Smolarczyk R; Skwarzyńska D; Kulik K; Szala S
    PLoS One; 2018; 13(1):e0191012. PubMed ID: 29320562
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tumor-associated macrophages: foe or accomplice of tumors?
    Ohno S; Suzuki N; Ohno Y; Inagawa H; Soma G; Inoue M
    Anticancer Res; 2003; 23(6a):4395-409. PubMed ID: 14666727
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel insight into cancer therapy: Lipid metabolism in tumor-associated macrophages.
    Ren Y; Wang M; Yuan H; Wang Z; Yu L
    Int Immunopharmacol; 2024 Jun; 135():112319. PubMed ID: 38801810
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Role of TAMs in the Regulation of Tumor Cell Resistance to Chemotherapy.
    McWhorter R; Bonavida B
    Crit Rev Oncog; 2024; 29(4):97-125. PubMed ID: 38989740
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of macrophages in the tumor microenvironment and tumor metabolism.
    Sadhukhan P; Seiwert TY
    Semin Immunopathol; 2023 Mar; 45(2):187-201. PubMed ID: 37002376
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tumor-associated macrophages as targets for tumor immunotherapy.
    Weigert A; Sekar D; Brüne B
    Immunotherapy; 2009 Jan; 1(1):83-95. PubMed ID: 20635976
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Current Strategies to Target Tumor-Associated-Macrophages to Improve Anti-Tumor Immune Responses.
    Anfray C; Ummarino A; Andón FT; Allavena P
    Cells; 2019 Dec; 9(1):. PubMed ID: 31878087
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 64.